Pixuvri 29 mg *
Pharmacy Only: Prescription

  • Company:

    Servier Laboratories Ireland Ltd
  • Status:

    Updated
  • Legal Category:

    Product subject to restricted prescription (C)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 30 November 2021

File name

Pixuvri 29mg PIL_1638273427.pdf

Reasons for updating

  • Improved presentation of PIL

Updated on 10 November 2021

File name

Pixuvri PIL_1636539736.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 16 November 2020

File name

Pixuvri SmPC_1605517248.pdf

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category:Product subject to restricted prescription (C)

Updated on 16 November 2020

File name

Pixuvri PIL_1605517208.pdf

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 18 June 2019

File name

Pixuvri 29mg_1560868711.pdf

Reasons for updating

  • File format updated to PDF

Legal category:Product subject to restricted prescription (C)

Updated on 26 September 2018

File name

Pixuvri PIL_1537948678.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 02 July 2018

File name

Pixuvri PIL.pdf

Reasons for updating

  • Change to section 6 - date of revision

Updated on 02 July 2018

File name

PIXUVRI.docx

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category:Product subject to restricted prescription (C)

Updated on 06 June 2018

File name

PIXUVRI.docx

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category:Product subject to restricted prescription (C)

Updated on 03 May 2017

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 03 May 2017

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

change to section 4.8 How to report a suspected adverse reaction - new contact details have been added

Updated on 28 April 2017

File name

PIL_16289_177.pdf

Reasons for updating

  • New PIL for new product

Updated on 28 April 2017

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 06 April 2017

Reasons for updating

  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

6.6. Reconstitution and dilution

 9. Date of last renewal

Updated on 01 June 2016

Reasons for updating

  • Change to date of revision

Updated on 25 May 2016

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

Date of latest renewal 22nd March 2016

Updated on 29 April 2015

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 20 April 2015

Reasons for updating

  • New PIL for new product